/COEPW

COEPW Stock - Coeptis Therapeutics Holdings, Inc.

Q: What is the analyst price target for COEPW?

Analyst price target information is not currently available for COEPW.

Q: What is COEPW's market cap?

Market capitalization information is not currently available for COEPW.

Healthcare|Biotechnology|NASDAQ

$0.01+1.72%

+$0.00 (+1.72%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for COEPW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.52

52W High$0.01

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	$75,000	$30,761
Gross Profit	$-1,038,632	$-1,001,236	$-1,001,384	$-372,413	$-933,456
Gross Margin	N/A	N/A	N/A	-496.6%	-3034.5%
Operating Income	$-10,054,488	$-21,491,125	$-34,195,964	$-14,045,932	$-6,861,403
Net Income	$-10,877,412	$-21,266,537	$-37,574,217	$-13,449,280	$-9,156,286
Net Margin	N/A	N/A	N/A	-17932.4%	-29765.9%
EPS	$-5.65	$-16.56	$-52.57	$-24.64	$-36.86

Company Overview

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Visit Website

Earnings History & Surprises

COEPW

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.03

Q4 2025

EPS Surprise History

Q4 22

No data

Q2 23

No data

Q3 25

No data

Q4 25

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 14, 2025	—	$-0.03	—	—
Q3 2025	Aug 14, 2025	—	$-0.95	—	—
Q2 2023	Jun 30, 2023	—	$-0.22	—	—
Q1 2023	Mar 31, 2023	—	—	—	—
Q4 2022	Dec 31, 2022	—	$-0.72	—	—

Frequently Asked Questions about COEPW

What is COEPW's current stock price?

Coeptis Therapeutics Holdings, Inc. (COEPW) is currently trading at $0.01 per share. The stock has moved +1.72% today.

What is the analyst price target for COEPW?

No analyst price targets are currently available for this stock.

What sector is Coeptis Therapeutics Holdings, Inc. in?

Coeptis Therapeutics Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is COEPW's market cap?

Coeptis Therapeutics Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does COEPW pay dividends?

No, Coeptis Therapeutics Holdings, Inc. does not currently pay a dividend to shareholders.